Hassan Mohamed Elsayed, Wadod Mohamed Abd Alfattah
Department of Anesthesia, Surgical Intensive Care Unit and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.
Indian J Anaesth. 2022 Feb;66(2):119-125. doi: 10.4103/ija.ija_257_21. Epub 2022 Feb 24.
Managing pain after thoracic surgery is crucial and the traditional methods have many adverse effects. We aimed to evaluate serratus anterior plane block (SAPB) and erector spinae plane block (ESPB) in acute pain control in thoracic cancer surgeries.
This randomised controlled, triple-blind study was performed on 90 patients, between 18 and 70 years old, scheduled for elective thoracic cancer surgery. Patients were allocated into three equal groups: Control group: received sham ESPB and sham SAPB. SAPB group received SAPB (20 ml bupivacaine 0.5%) and sham ESPB. ESBP group received ESPB (20 ml bupivacaine 0.5%) and sham SAPB.
Postoperative morphine consumption was significantly lower in ESBP and SAPB groups than control group [ESPB (8.52 ± 4.29 mg) < SAPB (19.57 ± 7.63 mg) < control (36.37 ± 8.27 mg)] ( < 0.001). Numerical rating scale pain score was comparable among the groups at rest, but was significantly lower at 30 min, 2, 4 h in ESPB and SAPB groups, than control group on coughing. The scores were better in SAPB compared to control group till 4 h. At 8, 12, 24 h, the difference between control and SAPB groups became insignificant, but it remained the least in ESPB group. Postoperative forced vital capacity and forced expiratory volume in the first second after 24 h were the best in ESPB group and better in SAPB group compared to the control group.
Both ESPB and SAPB reduced intraoperative and postoperative opioid consumptions and postoperative dynamic pain scores with improved postoperative pulmonary functions in thoracic surgery with the ESPB being superior.
胸外科手术后的疼痛管理至关重要,传统方法存在诸多不良反应。我们旨在评估前锯肌平面阻滞(SAPB)和竖脊肌平面阻滞(ESPB)在胸段癌症手术急性疼痛控制中的效果。
本随机对照、三盲研究纳入了90例年龄在18至70岁之间、计划接受择期胸段癌症手术的患者。患者被分为三组,每组人数相等:对照组:接受假ESPB和假SAPB。SAPB组接受SAPB(20毫升0.5%布比卡因)和假ESPB。ESBP组接受ESPB(20毫升0.5%布比卡因)和假SAPB。
ESBP组和SAPB组术后吗啡用量显著低于对照组[ESPB(8.52±4.29毫克)<SAPB(19.57±7.63毫克)<对照组(36.37±8.27毫克)](<0.001)。静息时各组数字评分法疼痛评分相当,但在咳嗽时,ESPB组和SAPB组在30分钟、2小时、4小时时的疼痛评分显著低于对照组。直到4小时,SAPB组的评分均优于对照组。在8小时、12小时、24小时时,对照组和SAPB组之间的差异不再显著,但ESPB组的差异最小。术后24小时后,ESPB组的术后用力肺活量和第1秒用力呼气量最佳,SAPB组优于对照组。
ESPB和SAPB均减少了胸段手术中及术后的阿片类药物用量和术后动态疼痛评分,并改善了术后肺功能,其中ESPB更具优势。